HarveyWSmith
@Harvey_W_SmithHe/him. Researcher, Senior Advisor & Consultant. Breast cancer, metabolism, epigenetics, scientific strategy, team science. All opinions are my own.
Similar User
@McGillGCI
@thomas_duchaine
@LDI_ILD
@Parklabmcgillu
@DanielaQuail
@MDankner
@Hellen_Kuasne
@ElenaK35
@gabe__brewer
@CMartinezR8
@OzgunV
@LauraHulea
@ronirayes
@GuojunChenLab
Thrilled to share this exciting breakthrough! 🎉Led by researchers @McGillMed's Goodman Cancer Institute, this paper was made possible through collaboration with @DFCI_BreastOnc and @Penn_CBIO Check it out!
New 📰now out in @NatureComms👉#Osteopontin is a therapeutic target that drives #BreastCancer recurrence, read the 🔓open access paper here: pubmed.ncbi.nlm.nih.gov/39448577/ @nlinmd @Parklabmcgillu @RMJesel
Bravo to our director, @MoragPark1, and researcher, @Zogopoulos, a member of both @RIMUHC1 and GCI, who received awards! This funding supports investigation of the genetics of rare breast cancers and hereditary risk factors for pancreas and gastrointestinal cancers.
📣 FUNDING ANNOUNCEMENT! 📣 Eight outstanding research teams will receive a total of $2.2M from @tfri_research and @MarathonOfHope to develop, validate, standardize and deploy new technologies to accelerate precision medicine for cancer. More ▶️ bit.ly/3UNbRnm (1/3)
Impressive findings shared by GCI investigator @DanielaQuail on the interplay between immune function, nutrition, and cancer progression at the #GCIGairdner2024
We’re all about collaboration! Great to see so many Quebec institutions, including @universitelaval, @IRIC_UMontreal, @LDI_IDL, and @RIMUHC1 coming together at the #GCIGairdner2024 conference. Science is stronger together! @FRQS1
Exciting start to the #GCIGairdner2024 conference with a plenary lecture by @GairdnerAwards Laureate @DanielJDrucker from @sinaihealth Fascinating insights into the clinical role of GLP-1 based medicines in obesity, cancer, and more!
Plenary lecture on obesity causes and treatment is underway! @GairderAwards laureate Jeffrey Friedman from @RockefellerUniv is presenting on the future of obesity research and how treatments have evolved. #GCIGairdner2024
Michael Pollak from @LDI_ILD is discussing how diet-regulated hormones can drive cancer progression. Can’t wait to hear more of his groundbreaking research! #GCIGairdner2024
So very proud of our team’s accomplishments in minimally invasive lung resection @MThoracics @mcgillsurgery @cusm_muhc @filippog92 presented our results on lobectomy and extended lobectomy for #NSCLC at #ITSOS24 @AATSHQ: 85% VATS; 3.3% conversion; 0.1% 30-day mortality; 6.8%…
The Rosalind and Morris Goodman Cancer Institute will host a special lay lecture on the science of eating, and how modern food shapes brains, bodies and health. Join us on October 17th at 4:30pm. Learn more and RSVP: tinyurl.com/3v4zr6b7
We are saddened to announce the passing of Philip E. Branton, a dear colleague, friend, and brilliant scientist whose career profoundly shaped cancer research. More about his legacy can be found here: goodmancancer.ca/en/news-detail…
The GCI is thrilled to share Prof. Peter Siegel was awarded $249,000 from the New Frontiers in Research Fund for the project “Single Cell Metabolomics: Uncovering Metabolic Heterogeneity and Revealing Novel Aspects of Tissue Architecture”. Read more: tinyurl.com/y6vpxcux
On #WorldLungCancerDay day, the GCI is reflecting on the important strides in lung cancer research have been achieved through the combined dedication of our researchers and the support of our donor community. Learn more : tinyurl.com/3f2r4r8y #WLCD24
GCI emeritus professor Nicole Beauchemin shares the promise of precision medicine to improve outcomes and quality of life for cancer patients.
90% of cancer patients diagnosed at Stage I, survive 5 years past diagnosis. But for Stage IV, this🔻 to <20%. In this context, we need to find better ways to detect – and intercept – cancers earlier. One way to do this? Precision medicine. Learn how ▶️ bit.ly/3SqIzZB
Thrilled to be a Canada Research Chair in Biomaterials and Biomacromolecule Delivery. Many thanks to the strong support from @McGillBME @McGillGCI, mentors, and all my team members. Thank you to @NSERC_CRSNG, the Canada Research Chairs program. Congrats to all other CRCs @mcgillu
Congrats Prof. Guojun Chen @GuojunChenLab, one of seven new Canada Research Chairs @mcgillu Also congrats to @McGillBME's associate members, Prof. Allen Ehrlicher and Prof. Xiaoqian Chai for their CRC renewal 🔬🇨🇦🎉
To improve outcomes for melanoma patients, this project led by the GCI and @RIMUHC1's @IanWatsonLab will bring together researchers and patients from across the country to work hand-in-hand and extend the reach of what we can achieve.
🆕🍁 New project deep dive: optimal #immunotherapy conditions in #metastatic #melanoma 🍁🆕 #immunecheckpointinhibitors (ICIs) are used to treat metastatic melanoma patients, but while some patients respond extremely well others do not or develop severe side-effects.
Congratulations @GuojunChenLab, CRC in Biomaterials and Biomacromolecule Delivery. The promise of his research to improve patient outcomes underscores how interdisciplinary research at the GCI will find the #knowledgetocure. Read more: tinyurl.com/ym3jctfe
Congratulations to the GCI and @RIMUHC1 's @IanWatsonLab, who is leading a funded study to identify predictors of immunotherapy response in melanoma patients. This project is a highly collaborative effort, bringing together researchers and patients across Canada.
📣 We're happy to join forces with @CDNCancerTrials to announce three new projects funded through our Pan-Canadian Project program! 📣 The projects focus on increasing the effectiveness of #immunotherapies for the benefit of cancer patients. Story ▶️ bit.ly/4crkL07
Honoring Dr. Jerry Pelletier's invaluable work in #RNA biology, therapeutics, and cancer research, a special event in May at @McGillu celebrated his legacy. Colleagues, students, and loved ones gathered to recognize his pioneering contributions. buff.ly/3KmSrjs
The GCI is proud to share researcher @loganawalsh is playing a key role in the computational analysis of this project to improve lung cancer immunotherapy, led by @DoctorJSpicer at the @RIMUHC1 Thank you @marathonofhope and partners for this investment in cancer research!
🆕 Introducing "Neoadjuvant precision therapy for non-small cell lung cancer: A platform for discovery" a new MOHCCN Pan-Canadian project 🫁 Full story 👉 bit.ly/3WA6pGi 🫁 Thread 👇
The Rosalind and Morris Goodman Cancer Institute is recognized for a legacy of excellence and high-impact discoveries. We are excited to also be recognized by our new visual identity! Learn more: tinyurl.com/227sj62k
United States Trends
- 1. Celtics 26,8 B posts
- 2. Cavs 24,9 B posts
- 3. #DWTS 2.712 posts
- 4. #RHOBH 2.031 posts
- 5. Joey Galloway N/A
- 6. #OnlyKash 76,9 B posts
- 7. $MADGUY N/A
- 8. Mobley 2.574 posts
- 9. Nancy Mace 98,6 B posts
- 10. #MCADE N/A
- 11. Pat Murphy 2.714 posts
- 12. Jaguar 71,8 B posts
- 13. Linda McMahon 8.460 posts
- 14. Queta N/A
- 15. Cenk 19,8 B posts
- 16. Lichtman 4.345 posts
- 17. Darius Garland 1.339 posts
- 18. Chile 170 B posts
- 19. Medicare and Medicaid 32,8 B posts
- 20. #spitemoney N/A
Who to follow
-
Rosalind & Morris Goodman Cancer Institute
@McGillGCI -
Thomas Duchaine
@thomas_duchaine -
Lady Davis Institute
@LDI_ILD -
Morag Park's lab at McGill
@Parklabmcgillu -
Daniela Quail Lab
@DanielaQuail -
Matt Dankner
@MDankner -
Hellen Kuasne
@Hellen_Kuasne -
Elena Kuzmin
@ElenaK35 -
gabrielle brewer
@gabe__brewer -
Constanza Martínez Ramírez
@CMartinezR8 -
Ozgun Varol
@OzgunV -
Laura Hulea
@LauraHulea -
Roni Rayes
@ronirayes -
Guojun Chen
@GuojunChenLab
Something went wrong.
Something went wrong.